SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

SVB Leerink Maintains Outperform on Acceleron Pharma, Raises Price Target to $132

SVB Leerink analyst Geoff Porges maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $127 to $132.

Benzinga · -
SVB Leerink analyst Geoff Porges maintains Acceleron Pharma (NASDAQ: XLRN) with a Outperform and raises the price target from $127 to $132.